Besides, the company offers PK or anti-drug antibodies (ADA) antibody preparation services, immunogenicity assays for multispecific antibodies, and serum concentration analysis, thus assisting ...

Immunotherapy, or antibody treatment that activates the patients own immune system against cancer, is increasingly being ...

A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration that immunogenicity assays may be necessary to measure immune responses to ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ...

The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site in Australia.